Search results
Merck KGaA (ETR:MRK) Is Due To Pay A Dividend Of €2.20
Simply Wall St. via Yahoo Finance· 2 hours agoA low payout ratio gives the company a lot of flexibility, and growing earnings also make it very...
Merck Stock Jumps After Dow Jones Stalwart Rides Its Cancer 'Star' To Another Quarterly Beat
Investor's Business Daily· 3 days agoMerck stock popped Thursday after the Dow Jones stalwart topped Wall Street's first-quarter views on...
Merck stock gains on Q1 2024 beat (NYSE:MRK)
Seeking Alpha· 3 days agoMerck (MRK) stock gains as the company posts better than expected Q1 2024 financials with strong sales growth from its cancer medicine Keytruda. Read...
Merck’s first-quarter results beat expectations amid healthy vaccine-sales growth
Market Watch· 3 days agoMerck & Co. Inc. on Thursday reported first-quarter results that beat analysts’ expectations amid...
Merck shares target raised on strong Q1 performance By Investing.com
Investing.com· 3 days agoThe firm has maintained a Buy rating on the stock following Merck's first-quarter revenue report,...
Merck stock target raised on strong Q1 results By Investing.com
Investing.com· 2 days ago(NYSE:MRK), increasing the price target to $140 from the previous $135, while maintaining an Equal...
Merck Stock Climbs After Higher-Than-Expected Sales of Cancer Drug Keytruda
The Wall Street Journal· 3 days agoShares of U.S. drugmaker Merck are up nearly 4% in recent trading after the company said its...
Will Higher Keytruda Sales Drive Merck's Q1
Forbes· 4 days agoMerck (NYSE: MRK) will report its Q1 2024 results on Thursday, April 25. As usual, Keytruda will be the driving growth for Merck with quarterly sales...
How Should You Play Merck (MRK) Stock Ahead of Q1 Earnings?
Zacks via Yahoo Finance· 6 days agoInvestor focus is likely to be on the sales of Merck's (MRK) blockbuster oncology medicine,...
Merck highlights progress on HIV, hypertension, cervical cancer drugs
WFMZ Eastern Pennsylvania and Western New Jersey· 3 days agoMerck got off to an excellent start in the first quarter of 2024. Wall Street met the news with...